4.0 Review

Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis

Journal

CHINESE JOURNAL OF CANCER
Volume 31, Issue 4, Pages 169-177

Publisher

SUN YAT SEN UNIV MED SCI WHO
DOI: 10.5732/cjc.011.10319

Keywords

Skp2; p53; RhoA; cellular senescence; metastasis; cancer therapy

Categories

Funding

  1. MD Anderson Cancer Center Trust Scholar Award
  2. NIH
  3. CPRIT
  4. DOD prostate cancer New Investigator Award
  5. MD Anderson Cancer Center Breast SPORE Career Development Award

Ask authors/readers for more resources

S-phase kinase-associated protein 2 (Skp2) belongs to the F-box protein family. It is a component of the SCF E3 ubiquitin ligase complex. Skp2 has been shown to regulate cellular proliferation by targeting several cell cycle-regulated proteins for ubiquitination and degradation, including cyclin-dependent kinase inhibitor p27. Skp2 has also been demonstrated to display an oncogenic function since its overexpression has been observed in many human cancers. This review discusses the recent discoveries on the novel roles of Skp2 in regulating cellular senescence, cancer progression, and metastasis, as well as the therapeutic potential of targeting Skp2 for human cancer treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available